E. Späth‐Schwalbe

3.4k total citations
56 papers, 2.1k citations indexed

About

E. Späth‐Schwalbe is a scholar working on Oncology, Endocrinology, Diabetes and Metabolism and Behavioral Neuroscience. According to data from OpenAlex, E. Späth‐Schwalbe has authored 56 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 12 papers in Endocrinology, Diabetes and Metabolism and 11 papers in Behavioral Neuroscience. Recurrent topics in E. Späth‐Schwalbe's work include Stress Responses and Cortisol (11 papers), Adrenal Hormones and Disorders (9 papers) and Circadian rhythm and melatonin (8 papers). E. Späth‐Schwalbe is often cited by papers focused on Stress Responses and Cortisol (11 papers), Adrenal Hormones and Disorders (9 papers) and Circadian rhythm and melatonin (8 papers). E. Späth‐Schwalbe collaborates with scholars based in Germany, United States and Switzerland. E. Späth‐Schwalbe's co-authors include Jan Born, Horst L. Fehm, W. Kern, Hubert Schrezenmeier, HL Fehm, Isabelle Genvresse, Stefan R. Bornstein, Franz Porzsolt, Kurt Possinger and Monika Ehrhart‐Bornstein and has published in prestigious journals such as Blood, The Journal of Clinical Endocrinology & Metabolism and Clinical Infectious Diseases.

In The Last Decade

E. Späth‐Schwalbe

55 papers receiving 2.1k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
E. Späth‐Schwalbe 558 473 437 406 329 56 2.1k
Michael Soyka 110 0.2× 128 0.3× 290 0.7× 207 0.5× 163 0.5× 126 3.0k
Mira Dalal 82 0.1× 262 0.6× 301 0.7× 252 0.6× 157 0.5× 21 1.6k
E Ferrari 288 0.5× 63 0.1× 217 0.5× 72 0.2× 363 1.1× 85 1.7k
Ayrton Custódio Moreira 477 0.9× 76 0.2× 312 0.7× 91 0.2× 1.4k 4.3× 145 3.1k
Georgia Trakada 63 0.1× 343 0.7× 542 1.2× 248 0.6× 60 0.2× 111 1.9k
Andrew Schrepf 143 0.3× 121 0.3× 77 0.2× 288 0.7× 42 0.1× 96 2.2k
Gordon Ohning 289 0.5× 26 0.1× 233 0.5× 186 0.5× 148 0.4× 129 2.8k
Nicola Pannacciulli 37 0.1× 350 0.7× 845 1.9× 320 0.8× 695 2.1× 59 4.6k
Laura Gianotti 209 0.4× 65 0.1× 968 2.2× 71 0.2× 1.5k 4.4× 111 2.8k
Yoshihiro Tanaka 226 0.4× 108 0.2× 55 0.1× 96 0.2× 47 0.1× 201 2.1k

Countries citing papers authored by E. Späth‐Schwalbe

Since Specialization
Citations

This map shows the geographic impact of E. Späth‐Schwalbe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Späth‐Schwalbe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Späth‐Schwalbe more than expected).

Fields of papers citing papers by E. Späth‐Schwalbe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Späth‐Schwalbe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Späth‐Schwalbe. The network helps show where E. Späth‐Schwalbe may publish in the future.

Co-authorship network of co-authors of E. Späth‐Schwalbe

This figure shows the co-authorship network connecting the top 25 collaborators of E. Späth‐Schwalbe. A scholar is included among the top collaborators of E. Späth‐Schwalbe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Späth‐Schwalbe. E. Späth‐Schwalbe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Felip, Enriqueta, David R. Spigel, Óscar Juan, et al.. (2021). 140P Preliminary results from PROPEL: A phase I/II study of bempegaldesleukin (BEMPEG: NKTR-214) plus pembrolizumab (PEMBRO) with or without chemotherapy in patients with metastatic NSCLC. Annals of Oncology. 32. S1438–S1440. 1 indexed citations
2.
Klamroth, Robert, Marianne Sinn, Sven Bischoff, et al.. (2021). Anticoagulation Practice in Patients with Cancer-Associated Thrombosis: Insights from GeCAT, a German Prospective Registry Study. Oncology Research and Treatment. 45(4). 178–185. 3 indexed citations
3.
Honecker, Friedemann, Gerd Kallischnigg, Werner Freier, et al.. (2021). Patient assessment and feasibility of treatment in older patients with cancer: results from the IN-GHO® Registry. Journal of Cancer Research and Clinical Oncology. 147(11). 3183–3194.
4.
Garbe, Edeltraut, Frank Andersohn, Elisabeth Bronder, et al.. (2011). Drug induced immune haemolytic anaemia in the Berlin Case‐Control Surveillance Study. British Journal of Haematology. 154(5). 644–653. 78 indexed citations
5.
Späth‐Schwalbe, E., Isabelle Genvresse, Larissa Krüger, et al.. (2002). Influence of amifostine on toxicity of CHOP in elderly patients with aggressive non-Hodgkinʼs lymphoma—a phase II study. Anti-Cancer Drugs. 13(4). 395–403. 10 indexed citations
6.
Lange, Tanja, Lisa Marshall, E. Späth‐Schwalbe, H. Fehm, & Jan Born. (2002). Systemic immune parameters and sleep after ultra-low dose administration of IL-2 in healthy men. Brain Behavior and Immunity. 16(6). 663–674. 17 indexed citations
7.
Genvresse, Isabelle, Diana Lüftner, E. Späth‐Schwalbe, & Frank Buttgereit. (2002). Prevalence and clinical significance of anticardiolipin and anti‐β2‐glycoprotein‐I antibodies in patients with non‐Hodgkin's lymphoma. European Journal Of Haematology. 68(2). 84–90. 39 indexed citations
8.
Genvresse, Isabelle, Frank Buttgereit, E. Späth‐Schwalbe, et al.. (2000). Arterial thrombosis associated with anticardiolipin and anti‐β2‐glycoprotein‐Iantibodies in patients with non‐Hodgkin's lymphoma: a report of two cases. European Journal Of Haematology. 65(5). 344–347. 16 indexed citations
9.
Späth‐Schwalbe, E., et al.. (2000). Phase II trial of gemcitabine in patients with pretreated advanced soft tissue sarcomas. Anti-Cancer Drugs. 11(5). 325–329. 61 indexed citations
10.
Späth‐Schwalbe, E., et al.. (1999). Successful Use of Liposomal Amphotericin B in a Case of Amphotericin B‐Induced Nephrogenic Diabetes Insipidus. Clinical Infectious Diseases. 28(3). 680–681. 10 indexed citations
11.
Kaufmann, Olaf, Bernd Flath, E. Späth‐Schwalbe, Kurt Possinger, & Manfred Dietel. (1999). Immunohistochemical Detection of CD10 with Monoclonal Antibody 56C6 on Paraffin Sections. American Journal of Clinical Pathology. 111(1). 117–122. 50 indexed citations
12.
Späth‐Schwalbe, E., et al.. (1998). Acute Effects of Recombinant Human Interleukin-6 on Endocrine and Central Nervous Sleep Functions in Healthy Men1. The Journal of Clinical Endocrinology & Metabolism. 83(5). 1573–1579. 127 indexed citations
13.
Schüler, Martin, U. Bruntsch, E. Späth‐Schwalbe, et al.. (1998). Lack of efficacy of recombinant human interleukin-6 in patients with advanced renal cell cancer: results of a phase II study. European Journal of Cancer. 34(5). 754–756. 15 indexed citations
14.
Funke, I., et al.. (1994). Subcutaneous IL-2 and Low-Dose IFN-α2a in the Treatment of Unselected Patients with Advanced Renal Cell Cancer. Oncology Research and Treatment. 17(3). 263–269. 4 indexed citations
15.
González-Hernández, J.A., SR Bornstein, Monika Ehrhart‐Bornstein, et al.. (1994). Interleukin-6 messenger ribonucleic acid expression in human adrenal gland in vivo: new clue to a paracrine or autocrine regulation of adrenal function.. The Journal of Clinical Endocrinology & Metabolism. 79(5). 1492–1497. 55 indexed citations
16.
Späth‐Schwalbe, E., et al.. (1994). Sleep and Wakefulness Affect the Responsiveness of the Pituitary-Adrenocortical Axis to Arginine Vasopressin in Humans. Neuroendocrinology. 60(5). 544–548. 19 indexed citations
17.
Späth‐Schwalbe, E., et al.. (1993). [Successful treatment of recurrent lower gastrointestinal hemorrhage in intestinal angiodysplasia with an estrogen-progesterone combination].. PubMed. 31(7-8). 447–9. 1 indexed citations
18.
Späth‐Schwalbe, E., et al.. (1989). Elevated plasma cortisol levels during interferon-γ treatment. Immunopharmacology. 17(3). 141–145. 27 indexed citations
19.
Fehm, HL, Reinhard W. Holl, E. Späth‐Schwalbe, Jan Born, & K. H. Voigt. (1988). Ability of corticotropin releasing hormone to stimulate cortisol secretion independent from pituitary adrenocorticotropin. Life Sciences. 42(6). 679–686. 50 indexed citations
20.
Becker, Kathrin, et al.. (1987). No Expression of ir-ACTH on Stimulated Peripheral Blood Leukocytes. Hormone and Metabolic Research. 19(12). 670–671. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Soyka Breakdown of academic impact, for papers by Mira Dalal Breakdown of academic impact, for papers by E Ferrari Breakdown of academic impact, for papers by Ayrton Custódio Moreira Breakdown of academic impact, for papers by Georgia Trakada Breakdown of academic impact, for papers by Andrew Schrepf Breakdown of academic impact, for papers by Gordon Ohning Breakdown of academic impact, for papers by Nicola Pannacciulli Breakdown of academic impact, for papers by Laura Gianotti Breakdown of academic impact, for papers by Yoshihiro Tanaka
Rankless by CCL
2026